In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men.

True or False: Pooled trial data showed that rheumatoid arthritis patients taking tofacitinib (Xeljanz) were less likely to gain weight. The FDA and CDC jointly recommended to pause use of the ...

In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.

Newer medications, such as Mounjaro and Wegovy, exhibit both more total weight lost and faster weight regain than older ...

Weight loss injections work by regulating your appetite by mimicking a naturally produced hormone called glucagon-like ...

Landmark research suggests the appetite-suppressing jabs which mimic a hormone that makes us feel full also significantly cut ...

Research on weight loss drugs like Ozempic shows varied results for mental health impacts, with some patients experiencing ...

The company behind the weight loss sensation that transformed bodies and bank accounts across America just showed its own CEO ...

Pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, says its CEO is stepping down.

A new study shows that people Zepbound lost about 50% more weight than those using Wegovy. It was the first head-to-head ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Eli Lilly’s obesity drug Zepbound led to nearly 50 percent more weight loss than Novo Nordisk’s Wegovy in the first direct ...